scholarly journals Impact of right–left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome

2019 ◽  
Vol 112 (5) ◽  
pp. 939-946 ◽  
Author(s):  
Brittany Y. Jarrett ◽  
Heidi Vanden Brink ◽  
Eric D. Brooks ◽  
Kathleen M. Hoeger ◽  
Steven D. Spandorfer ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ultrasound Diagnosis ◽  
Ovary Syndrome ◽  
Ovarian Morphology

scholarly journals The New Three-dimensional Ultrasound Modes allow a Better Polycystic Ovary Syndrome Ultrasound Diagnosis beyond the Rotterdam Criteria

2015 ◽  
Vol 9 (4) ◽  
pp. 434-445
Author(s):  
Francisco Raga ◽  
Oscar Caballero ◽  
Francisco Bonilla ◽  
Fernando Bonilla-Musoles ◽  
Juan Carlos Castillo
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Three Dimensional ◽  
3D Ultrasound ◽  
Ultrasound Diagnosis ◽  
Ovary Syndrome ◽  
Ovarian Morphology ◽  
Exact Etiology ◽  
Definition Of ◽  
Rotterdam Criteria

ABSTRACT Polycystic ovary syndrome (PCOS) is a complex endocrine condition affecting reproductive-aged women. The exact etiology of this condition remains elusive and the definition of the syndrome has undergone several revisions in which ovarian morphology plays a central role. This review describes several and modern three-dimensional (3D) ultrasound modes including: HDliveTM, virtual organ computer-aided analysis (VOCAL), inversion mode, Radiance System ArchitectureTM, for the study of PCOS-related ovarian morphology. This state-of-the-art technology should be employed—when available, in the evaluation of PCOS-related ovarian morphology. How to cite this article Raga F, Bonilla F Jr, Caballero O, Castillo JC, Bonilla-Musoles F. The New Three-dimensional Ultrasound Modes allow a Better Polycystic Ovary Syndrome Ultrasound Diagnosis beyond the Rotterdam Criteria. Donald School J Ultrasound Obstet Gynecol 2015;9(4):434-445.

Metformin Therapy Improves Ovarian Morphology in Polycystic Ovary Syndrome Patients (PCOS)

2005 ◽  
Vol 83 (5) ◽  
pp. S10
Author(s):  
A. Bayrak ◽  
H. Terbell ◽  
R. Urwitz-Lane ◽  
F.Z. Stanczyk ◽  
R.J. Paulson
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Metformin Therapy ◽  
Ovarian Morphology

scholarly journals Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus

2013 ◽  
Vol 4 (3) ◽  
pp. 326-329 ◽  
Author(s):  
Arina Miyoshi ◽  
So Nagai ◽  
Masamitsu Takeda ◽  
Takuma Kondo ◽  
Hiroshi Nomoto ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Polycystic Ovary Syndrome ◽  
Type 1 Diabetes Mellitus ◽  
Polycystic Ovary ◽  
Japanese Women ◽  
Ovary Syndrome ◽  
Ovarian Morphology

scholarly journals Polycystic Ovarian Morphology in Normal Women Does Not Predict the Development of Polycystic Ovary Syndrome

2006 ◽  
Vol 91 (10) ◽  
pp. 3878-3884 ◽  
Author(s):  
M. K. Murphy ◽  
J. E. Hall ◽  
J. M. Adams ◽  
H. Lee ◽  
C. K. Welt
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Outpatient Setting ◽  
Ovary Syndrome ◽  
Ovarian Morphology ◽  
Menstrual History ◽  
Irregular Menses ◽  
Normal Women ◽  
Over Time

Abstract Context: Polycystic ovarian morphology (PCOM) is present in 25% of normal women in the absence of polycystic ovary syndrome (PCOS); however, the natural history of PCOM is unknown. Objective: We hypothesized that the presence of PCOM predisposes the development of PCOS. Design: The study was a longitudinal follow-up study over 8.2 ± 5.2 yr (mean ± sd; range 1.7–17.5 yr). Setting: The study took place in an outpatient setting. Subjects: Women who took part in a previous study as a normal control and had an ultrasound examination (n = 40) participated. Intervention: Subjects underwent an interval menstrual history, physical exam, blood sampling, and repeat ultrasound in the follicular phase. Main Outcome Measure: Development of PCOS was diagnosed by irregular menses and hyperandrogenism, in the absence of other disorders. Changes in ovarian morphology over time were evaluated. Results: At the baseline visit, 23 women (57.5%) had PCOM and 17 (42.5%) had normal ovarian morphology. One subject with PCOM developed irregular menses and presumptive PCOS. Eleven subjects with PCOM no longer met the criteria for PCOM at follow-up. There was no factor that predicted the change to normal ovarian morphology at the follow-up visit. Conclusions: These data suggest that PCOM in women with regular ovulatory cycles does not commonly predispose the development of PCOS. Although it is unusual to develop PCOM if the ovaries are normal on first assessment, ovaries in women with PCOM no longer meet the criteria for PCOM in approximately half of cases over time.

Ovarian morphology and endocrine function in polycystic ovary syndrome

2011 ◽  
Vol 284 (6) ◽  
pp. 1443-1448 ◽  
Author(s):  
Gilberto Tena ◽  
Carlos Moran ◽  
Rocio Romero ◽  
Segundo Moran
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Endocrine Function ◽  
Ovary Syndrome ◽  
Ovarian Morphology

scholarly journals Contemporary approaches to the management of polycystic ovary syndrome

2018 ◽  
Vol 9 (4) ◽  
pp. 123-134 ◽  
Author(s):  
Renato Pasquali
Keyword(s):  
Insulin Resistance ◽  
Polycystic Ovary Syndrome ◽  
Ovarian Function ◽  
Polycystic Ovary ◽  
Review Article ◽  
Metabolic Abnormalities ◽  
Androgen Excess ◽  
Ovary Syndrome ◽  
Ovulatory Dysfunction ◽  
Ovarian Morphology

Polycystic ovary syndrome (PCOS) is a common disorder in women in their reproductive years and is characterized by androgen excess, ovulatory dysfunction, and polycystic ovarian morphology. It is also associated with several metabolic abnormalities, particularly insulin resistance and obesity, which play an important role in the pathophysiology of PCOS and, in particular, negatively influence ovarian function and fertility. This review article summarizes the available treatment for women with PCOS. Specifically, current and potentially new therapies are discussed.

Sign in / Sign up

Export Citation Format

Share Document